PORT ST. LUCIE, Fla.--(BUSINESS WIRE)--It’s another soaking wet rainy season in South Florida, and with it comes ideal conditions for mosquitos to breed and thrive, but this summer brings fears beyond just a pesky bite with the U.S. arrival of the debilitating mosquito-spread virus, chikungunya. Mosquitos can easily and efficiently transmit this virus to humans causing high fever, severe muscle/joint pain, headache, fatigue and rash. While there is currently no FDA-approved vaccine to prevent the spread of the chikungunya virus, the head of viral immunity research at the Vaccine & Gene Therapy Institute of Florida (VGTI Florida®), a leading non-profit biomedical research institute, has developed a new platform vaccine technology that is expected to provide complete protection against chikungunya virus infection.